Text
Behind every statistic is a person, a family and a story.
Screening is not about expecting bad news. It is about reducing uncertainty, and giving you and your clinician more options while there are more options to have.
Dr. Anna Rodecki
Clinical advisor
Healthcare is full of statistics. But behind every statistic is a person, a family and a story.
For Anna R., supporting hospice patients and walking alongside her father through cancer changed the way she thinks about early detection. Those experiences reinforced something simple: by the time many cancers are diagnosed, the choices available to patients and families have already begun to narrow.
That’s why early detection matters.
Not simply to find disease earlier, but because it can preserve time, choices and the opportunity to act before cancer begins to shape someone’s and a family’s future.
Everyone working in early detection has a reason they care.
This is Anna’s.
Originally shared on LinkedIn
Join the conversation and see how others have responded.
Advancing infrared applications for earlier detection — beginning with lung cancer.
AIR-DS is a UKCA marked in vitro diagnostic medical device, developed in accordance with IEC 62304 and under an ISO 13485 certified quality management system. In the US, a CLIA certified laboratory will offer a laboratory developed test (LDT) with AIR-DS Lung Test. It has not been cleared or approved by the FDA. Information on this website is provided for educational and informational purposes and should not be interpreted as medical advice.